Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Engineered Skin Substitute

· Amarantus BioScience Holdings, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Engineered Skin Substitute, covering 2016-08-31 to 2016-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds [Phase 2]

See pricing